Rao X, Chen Y, Beyrer J, Nash Smyth E, et al. Clinical and Genomic Characteristics of Patients with HR+, HER2- Metastatic Breast Cancer Following Progression on a CDK4 and 6 Inhibitor. Clin Cancer Res 2023 Jun 8:CCR-22-3843. doi: 10.1158/1078-0432.CCR-22-3843.
PMID: 37289194